Advances in Virus-Like Particle Vaccines for Filoviruses

Virus-Like Particles as Particulate Vaccines

(2010) Luigi Buonaguro et al.   CURRENT HIV RESEARCH

Viral strategies for the evasion of immunogenic cell death

(2010) L. Galluzzi et al.   JOURNAL OF INTERNAL MEDICINE

Oligomerization of Ebola Virus VP40 Is Essential for Particle Morphogenesis and Regulation of Viral Transcription

(2010) T. Hoenen et al.   JOURNAL OF VIROLOGY

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

(2010) Charalampos Valmas et al.   PLoS Pathogens

Disease modeling for Ebola and Marburg viruses

(2009) D. Bente et al.   Disease Models & Mechanisms

Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever

(2009) K. L. Warfield et al.   JOURNAL OF VIROLOGY

Conserved Motifs within Ebola and Marburg Virus VP40 Proteins Are Important for Stability, Localization, and Subsequent Budding of Virus-Like Particles

(2009) Y. Liu et al.   JOURNAL OF VIROLOGY

Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus

(2009) Jonas Näslund et al.   VIROLOGY

Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses

(2008) Dana L Swenson et al.   Expert Review of Vaccines

Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

(2008) T. W. Geisbert et al.   JOURNAL OF VIROLOGY

Protection against lethal challenge by Ebola virus-like particles produced in insect cells

(2008) Yuliang Sun et al.   VIROLOGY